CVS GroupCVSGF 90 3-Year RORE % is 23.78 as of Dec. 2025. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $17.94 (Fairly Valued). The stock has 3 warning signs investors should review. Among 605 Healthcare Providers & Services companies, CVS Group ranks better than 70.41% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
CVS Group's 3-Year RORE % for the quarter that ended in Dec. 2025 was 23.78%.
The industry rank for CVS Group's 3-Year RORE % or its related term are showing as below:
CVSGF's 3-Year RORE % is ranked better than 70.41% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: -0.32
vs CVSGF: 23.78
CVS Group (OTCPK:CVSGF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
CVS Group 3-Year RORE % Related Terms
CVS Group 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for CVS Group's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, CVS Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where CVS Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
CVS Group (CVSGF) has a 3-Year RORE % of 23.78 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on CVS Group and its competitors. According to the industry distribution chart, CVS Group ranks #179 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 29.6%.
Is CVS Group's 3-Year RORE % too high?
CVS Group's current 3-Year RORE % is 23.78. Based on the distribution chart, CVS Group ranks #179 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CVS Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #179 out of 605 companies for 3-Year RORE %. This puts CVS Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on CVS Group and its competitors. CVS Group's current 3-Year RORE % is 23.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Fairly Valued. The stock's GF Value™ is $17.94, compared to a current price of $16.55 — trading 7.7% below its estimated fair value. The current 3-Year RORE % is 23.78. CVS Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For CVS Group (CVSGF), the current 3-Year RORE % is 23.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $16.55 is trading 7.7% below its estimated GF Value™ of $17.94.
GuruFocus considers CVS Group to be Fairly Valued.
Key valuation signals for CVSGF:
3-Year RORE %: 23.78
GF Value™: $17.94 vs. price of $16.55 (7.7% below fair value)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score
Get the complete analysis for CVSGF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
